Insulin-like growth factor-1 receptor regulation in activated human T lymphocytes

Hormone Research

Volumn 59, Issue 6, 2003, Pages 276-280

  Segretin, María Eugenia ^a   Galeano, Adriana ^b   Roldán, Alicia ^a   Schillaci, Roxana ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b Sanatorio Mater Dei   (Argentina)

Author keywords

Down regulation; Insulin like growth factor 1 receptor; T lymphocyte; Up regulation

Indexed keywords

MESSENGER RNA; PHYTOHEMAGGLUTININ; SOMATOMEDIN C RECEPTOR;

ARTICLE; CELL MEMBRANE; CELL SURFACE; CELL TRANSPORT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KINETICS; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; KINETICS; LYMPHOCYTE ACTIVATION; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; UP-REGULATION;

EID: 0038017014     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070625     Document Type: Article

References (11)

1. Brocardo MG, Schillaci R, Galeano A, Radrizzani M, White V, González Gerrico A, Santa-Coloma TA, Roldán A: Early effects of IGF-1 in activated human T lymphocytes. J Leuk Biol 2001;70:297-305.
2. Zapf A, Hsu D, Olefsky JM: Comparison of the intracellular itineraries of insulin-like growth factor-I and insulin and their receptors in Rat-1 fibroblasts. Endocrinology 1994;134:2445-2452.
3. Schillaci R, Brocardo MG, Galeano A, Roldán A: Down-regulation of insulin like-growth factor-1 receptor (IGF-1R) expression in human T lymphocytes activation. Cell Immunol 1998;183:157-161.
4. Johnson EW, Jones LA, Kozak RW: Expression and function of insulin-like growth factor receptors on anti-CD3-activated human T lymphocytes. J Immunol 1992;148:63-71.
5. Walsh PT, O'Connor R: The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis. Eur J Immunol 2000;30:1010-1018.
6. Tapson VF, Boni-Schnetzler M, Pilch PF, Center DM, Berman JS: Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro. J Clin Invest 1988;82:950-957.
7. Quinn KA, Treston AM, Unsworth EJ, Miller M-J, Vos M, Grimley C, Battey J, Mulshine JL, Cuttitta FJ: Insulin-like growth factor expression in human cancer cell lines. J Biol Chem 1996;271:11477-11483.
8. Zhou L, Ritchie D, Wang EY, Barbone AG, Argentieri D, Lau CY: Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A. J Immunol 1994;153:5026-5037.
9. Hartmann KKP, Baier TG, Papa V, Kronenwett ME, Brown J, Golfine IR, Rosenthal SMJ: A monoclonal antibody to the T-cell receptor increases IGF-I receptor content in normal T-lymphocytes: Comparison with phytohemagglutinin. Cell Biochem 1992;48:81-85.
10. Reiss K, Porcu P, Sell C, Pietrzkowski Z, Baserga R: The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells. Oncogene 1992;7:2243-2248.
11. Condorelli G, Bueno R, Smith RJ: Two alternatively spliced forms of the human insulin-like growth factor I receptor have distinct biological activities and internalization kinetics. J Biol Chem 1994;269:8510-8516.